+ All Categories
Home > Documents > Metabolomics for Characterizing the Human Exposomenas-sites.org/emergingscience/files/2015/06/...VD...

Metabolomics for Characterizing the Human Exposomenas-sites.org/emergingscience/files/2015/06/...VD...

Date post: 03-Jul-2020
Category:
Upload: others
View: 1 times
Download: 0 times
Share this document with a friend
35
Metabolomics for Characterizing the Human Exposome: The need for a unied and high-throughput way to ascertain environmental exposures Chirag J Patel 5/28/2015 [email protected] @chiragjp www.chiragjpgroup.org Center for Biomedical Informatics Harvard Medical School Center for Assessment Technology and Continuous Health (CATCH) Massachusetts General Hospital
Transcript
Page 1: Metabolomics for Characterizing the Human Exposomenas-sites.org/emergingscience/files/2015/06/...VD BPer t t T2D. . . individuals GWAS, RVAS, pathway analysis..etc. EWAS, PheWAS..etc.

Metabolomics for Characterizing the Human Exposome:

The need for a unified and high-throughput way to ascertain environmental exposures

Chirag J Patel 5/28/2015

[email protected] @chiragjp

www.chiragjpgroup.org

Center for Biomedical Informatics Harvard Medical School Center for Assessment Technology and Continuous Health (CATCH) Massachusetts General Hospital

Page 2: Metabolomics for Characterizing the Human Exposomenas-sites.org/emergingscience/files/2015/06/...VD BPer t t T2D. . . individuals GWAS, RVAS, pathway analysis..etc. EWAS, PheWAS..etc.

Thank you

Steven Rappaport

David Balshaw

Toby Athersuch

Erin Baker

Anthony Macharone

Dean JonesAndrew Patterson

Susan Sumner

Oliver Fiehn

Pieter Dorrestein

Elaine Cohen Hubal

Benjamin Blount

Roel Vermeulen

Page 3: Metabolomics for Characterizing the Human Exposomenas-sites.org/emergingscience/files/2015/06/...VD BPer t t T2D. . . individuals GWAS, RVAS, pathway analysis..etc. EWAS, PheWAS..etc.

We claimed:

Page 4: Metabolomics for Characterizing the Human Exposomenas-sites.org/emergingscience/files/2015/06/...VD BPer t t T2D. . . individuals GWAS, RVAS, pathway analysis..etc. EWAS, PheWAS..etc.

Metabolomics technologies…

… can enable the comprehensive and accessible assessment of the high-throughput human exposome,

We claimed:

Page 5: Metabolomics for Characterizing the Human Exposomenas-sites.org/emergingscience/files/2015/06/...VD BPer t t T2D. . . individuals GWAS, RVAS, pathway analysis..etc. EWAS, PheWAS..etc.

Metabolomics technologies…

… can enable the comprehensive and accessible assessment of the high-throughput human exposome,

…accelerate data-driven discovery in health and disease,

We claimed:

Page 6: Metabolomics for Characterizing the Human Exposomenas-sites.org/emergingscience/files/2015/06/...VD BPer t t T2D. . . individuals GWAS, RVAS, pathway analysis..etc. EWAS, PheWAS..etc.

Metabolomics technologies…

… can enable the comprehensive and accessible assessment of the high-throughput human exposome,

…accelerate data-driven discovery in health and disease,

…and have wide-reaching implications in health policy and decision making.

We claimed:

Page 7: Metabolomics for Characterizing the Human Exposomenas-sites.org/emergingscience/files/2015/06/...VD BPer t t T2D. . . individuals GWAS, RVAS, pathway analysis..etc. EWAS, PheWAS..etc.

Motivation

Page 8: Metabolomics for Characterizing the Human Exposomenas-sites.org/emergingscience/files/2015/06/...VD BPer t t T2D. . . individuals GWAS, RVAS, pathway analysis..etc. EWAS, PheWAS..etc.

P = G + E

Page 9: Metabolomics for Characterizing the Human Exposomenas-sites.org/emergingscience/files/2015/06/...VD BPer t t T2D. . . individuals GWAS, RVAS, pathway analysis..etc. EWAS, PheWAS..etc.

P = G + E

Page 10: Metabolomics for Characterizing the Human Exposomenas-sites.org/emergingscience/files/2015/06/...VD BPer t t T2D. . . individuals GWAS, RVAS, pathway analysis..etc. EWAS, PheWAS..etc.

P = G + EHeight

Eye colorType 2 Diabetes

Cancer

Phenome

Page 11: Metabolomics for Characterizing the Human Exposomenas-sites.org/emergingscience/files/2015/06/...VD BPer t t T2D. . . individuals GWAS, RVAS, pathway analysis..etc. EWAS, PheWAS..etc.

P = G + EHeight

Eye colorType 2 Diabetes

Cancer

Phenome Genome

~10M SNPs

Page 12: Metabolomics for Characterizing the Human Exposomenas-sites.org/emergingscience/files/2015/06/...VD BPer t t T2D. . . individuals GWAS, RVAS, pathway analysis..etc. EWAS, PheWAS..etc.

P = G + EHeight

Eye colorType 2 Diabetes

Cancer

Phenome Genome

~10M SNPs

Environment

Infectious agents Nutrients Pollutants

Pharmaceuticals

Page 13: Metabolomics for Characterizing the Human Exposomenas-sites.org/emergingscience/files/2015/06/...VD BPer t t T2D. . . individuals GWAS, RVAS, pathway analysis..etc. EWAS, PheWAS..etc.

P = G + EPhenotypes (P) emerge due to genes (G) and environments (E)…

Page 14: Metabolomics for Characterizing the Human Exposomenas-sites.org/emergingscience/files/2015/06/...VD BPer t t T2D. . . individuals GWAS, RVAS, pathway analysis..etc. EWAS, PheWAS..etc.

P = G + EPhenotypes (P) emerge due to genes (G) and environments (E)…

... and we’re exposed to many environmental factors of the exposome...

Page 15: Metabolomics for Characterizing the Human Exposomenas-sites.org/emergingscience/files/2015/06/...VD BPer t t T2D. . . individuals GWAS, RVAS, pathway analysis..etc. EWAS, PheWAS..etc.

P = G + EPhenotypes (P) emerge due to genes (G) and environments (E)…

but, we lack methods to ascertain and assess high-throughput E.

... and we’re exposed to many environmental factors of the exposome...

Page 16: Metabolomics for Characterizing the Human Exposomenas-sites.org/emergingscience/files/2015/06/...VD BPer t t T2D. . . individuals GWAS, RVAS, pathway analysis..etc. EWAS, PheWAS..etc.

... a unified, accessible, cost-effective platform has allowed for high-throughput discovery of G in disease!

G:

image from illumina, inc

O($100)

Page 17: Metabolomics for Characterizing the Human Exposomenas-sites.org/emergingscience/files/2015/06/...VD BPer t t T2D. . . individuals GWAS, RVAS, pathway analysis..etc. EWAS, PheWAS..etc.

... a unified, accessible, cost-effective platform has allowed for high-throughput discovery of G in disease!

>1,400 Genome-wide Association Studies (GWAS)

NHGRI GWAS Catalog https://www.genome.gov/

G:

image from illumina, inc

O($100)

Page 18: Metabolomics for Characterizing the Human Exposomenas-sites.org/emergingscience/files/2015/06/...VD BPer t t T2D. . . individuals GWAS, RVAS, pathway analysis..etc. EWAS, PheWAS..etc.

E?

Page 19: Metabolomics for Characterizing the Human Exposomenas-sites.org/emergingscience/files/2015/06/...VD BPer t t T2D. . . individuals GWAS, RVAS, pathway analysis..etc. EWAS, PheWAS..etc.

σP = σG + σE

Page 20: Metabolomics for Characterizing the Human Exposomenas-sites.org/emergingscience/files/2015/06/...VD BPer t t T2D. . . individuals GWAS, RVAS, pathway analysis..etc. EWAS, PheWAS..etc.

σG

σP H2 =

Heritability (H2) is the range of phenotypic variability attributed to genetic variability in a population

Indicator of the proportion of phenotypic differences attributed to the genomic differences.

Page 21: Metabolomics for Characterizing the Human Exposomenas-sites.org/emergingscience/files/2015/06/...VD BPer t t T2D. . . individuals GWAS, RVAS, pathway analysis..etc. EWAS, PheWAS..etc.

Eye colorHair curliness

Type-1 diabetesHeight

SchizophreniaEpilepsy

Graves' diseaseCeliac disease

Polycystic ovary syndromeAttention deficit hyperactivity disorder

Bipolar disorderObesity

Alzheimer's diseaseAnorexia nervosa

PsoriasisBone mineral density

Menarche, age atNicotine dependence

Sexual orientationAlcoholism

LupusRheumatoid arthritis

Crohn's diseaseMigraine

Thyroid cancerAutism

Blood pressure, diastolicBody mass index

DepressionCoronary artery disease

InsomniaMenopause, age at

Heart diseaseProstate cancer

QT intervalBreast cancer

Ovarian cancerHangoverStrokeAsthma

Blood pressure, systolicHypertensionOsteoarthritis

Parkinson's diseaseLongevity

Type-2 diabetesGallstone diseaseTesticular cancer

Cervical cancerSciatica

Bladder cancerColon cancerLung cancerLeukemia

Stomach cancer

0 25 50 75 100Heritability: Var(G)/Var(Phenotype) Source: SNPedia.com

H2 estimates for complex traits are low and variable: massive opportunity for exposome research

Page 22: Metabolomics for Characterizing the Human Exposomenas-sites.org/emergingscience/files/2015/06/...VD BPer t t T2D. . . individuals GWAS, RVAS, pathway analysis..etc. EWAS, PheWAS..etc.

Eye colorHair curliness

Type-1 diabetesHeight

SchizophreniaEpilepsy

Graves' diseaseCeliac disease

Polycystic ovary syndromeAttention deficit hyperactivity disorder

Bipolar disorderObesity

Alzheimer's diseaseAnorexia nervosa

PsoriasisBone mineral density

Menarche, age atNicotine dependence

Sexual orientationAlcoholism

LupusRheumatoid arthritis

Crohn's diseaseMigraine

Thyroid cancerAutism

Blood pressure, diastolicBody mass index

DepressionCoronary artery disease

InsomniaMenopause, age at

Heart diseaseProstate cancer

QT intervalBreast cancer

Ovarian cancerHangoverStrokeAsthma

Blood pressure, systolicHypertensionOsteoarthritis

Parkinson's diseaseLongevity

Type-2 diabetesGallstone diseaseTesticular cancer

Cervical cancerSciatica

Bladder cancerColon cancerLung cancerLeukemia

Stomach cancer

0 25 50 75 100Heritability: Var(G)/Var(Phenotype) Source: SNPedia.com

H2 estimates for complex traits are low and variable: massive opportunity for exposome research

exposome

Page 23: Metabolomics for Characterizing the Human Exposomenas-sites.org/emergingscience/files/2015/06/...VD BPer t t T2D. . . individuals GWAS, RVAS, pathway analysis..etc. EWAS, PheWAS..etc.

©20

15N

atur

e A

mer

ica,

Inc.

All

righ

ts r

eser

ved.

NATURE GENETICS ADVANCE ONLINE PUBLICATION 1

A N A LY S I S

Despite a century of research on complex traits in humans, the relative importance and specific nature of the influences of genes and environment on human traits remain controversial. We report a meta-analysis of twin correlations and reported variance components for 17,804 traits from 2,748 publications including 14,558,903 partly dependent twin pairs, virtually all published twin studies of complex traits. Estimates of heritability cluster strongly within functional domains, and across all traits the reported heritability is 49%. For a majority (69%) of traits, the observed twin correlations are consistent with a simple and parsimonious model where twin resemblance is solely due to additive genetic variation. The data are inconsistent with substantial influences from shared environment or non-additive genetic variation. This study provides the most comprehensive analysis of the causes of individual differences in human traits thus far and will guide future gene-mapping efforts. All the results can be visualized using the MaTCH webtool.

Specifically, the partitioning of observed variability into underlying genetic and environmental sources and the relative importance of additive and non-additive genetic variation are continually debated1–5. Recent results from large-scale genome-wide association studies (GWAS) show that many genetic variants contribute to the variation in complex traits and that effect sizes are typically small6,7. However, the sum of the variance explained by the detected variants is much smaller than the reported heritability of the trait4,6–10. This ‘missing heritability’ has led some investigators to conclude that non-additive variation must be important4,11. Although the presence of gene-gene interaction has been demonstrated empirically5,12–17, little is known about its relative contribution to observed variation18.

In this study, our aim is twofold. First, we analyze empirical esti-mates of the relative contributions of genes and environment for virtually all human traits investigated in the past 50 years. Second, we assess empirical evidence for the presence and relative importance of non-additive genetic influences on all human traits studied. We rely on classical twin studies, as the twin design has been used widely to disentangle the relative contributions of genes and environment, across a variety of human traits. The classical twin design is based on contrasting the trait resemblance of monozygotic and dizygotic twin pairs. Monozygotic twins are genetically identical, and dizygotic twins are genetically full siblings. We show that, for a majority of traits (69%), the observed statistics are consistent with a simple and parsi-monious model where the observed variation is solely due to additive genetic variation. The data are inconsistent with a substantial influence from shared environment or non-additive genetic variation. We also show that estimates of heritability cluster strongly within functional domains, and across all traits the reported heritability is 49%. Our results are based on a meta-analysis of twin correlations and reported variance components for 17,804 traits from 2,748 publications includ-ing 14,558,903 partly dependent twin pairs, virtually all twin studies of complex traits published between 1958 and 2012. This study provides the most comprehensive analysis of the causes of individual differences in human traits thus far and will guide future gene-mapping efforts. All results can be visualized with the accompanying MaTCH webtool.

RESULTSThe distribution of studied traits is nonrandomWe systematically retrieved published classical twin studies in which observed variation in human traits was partitioned into genetic and environmental influences. For each study, we collected reported

Meta-analysis of the heritability of human traits based on fifty years of twin studiesTinca J C Polderman1,10, Beben Benyamin2,10, Christiaan A de Leeuw1,3, Patrick F Sullivan4–6, Arjen van Bochoven7, Peter M Visscher2,8,11 & Danielle Posthuma1,9,11

1Department of Complex Trait Genetics, VU University, Center for Neurogenomics and Cognitive Research, Amsterdam, the Netherlands. 2Queensland Brain Institute, University of Queensland, Brisbane, Queensland, Australia. 3Institute for Computing and Information Sciences, Radboud University Nijmegen, Nijmegen, the Netherlands. 4Center for Psychiatric Genomics, Department of Genetics, University of North Carolina, Chapel Hill, North Carolina, USA. 5Department of Psychiatry, University of North Carolina, Chapel Hill, North Carolina, USA. 6Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden. 7Faculty of Sciences, VU University, Amsterdam, the Netherlands. 8University of Queensland Diamantina Institute, Translational Research Institute, Brisbane, Queensland, Australia. 9Department of Clinical Genetics, VU University Medical Center, Neuroscience Campus Amsterdam, Amsterdam, the Netherlands. 10These authors contributed equally to this work. 11These authors jointly supervised this work. Correspondence should be addressed to D.P. ([email protected]).

Received 13 February; accepted 1 April; published online 18 May 2015; doi:10.1038/ng.3285

Insight into the nature of observed variation in human traits is impor-tant in medicine, psychology, social sciences and evolutionary biology. It has gained new relevance with both the ability to map genes for human traits and the availability of large, collaborative data sets to do so on an extensive and comprehensive scale. Individual differences in human traits have been studied for more than a century, yet the causes of variation in human traits remain uncertain and controversial.

Nature Genetics, 2015

17,804 traits of the phenome 2,748 publications

14,558,903 twin pairs

Average H2 (genome): 0.49

Exposome plays an equal role.

Page 24: Metabolomics for Characterizing the Human Exposomenas-sites.org/emergingscience/files/2015/06/...VD BPer t t T2D. . . individuals GWAS, RVAS, pathway analysis..etc. EWAS, PheWAS..etc.

A data-driven and accessible and view of the environment is required to discover the cause of burdensome

diseases today.

Wild, 2005 Rappaport and Smith, 2010, 2011

Buck-Louis and Sundaram 2012 Miller and Jones, 2014

Patel CJ and Ioannidis JPAI, 2014

Explaining the other 51%: A new data-driven and cost-effective paradigm for

discovery of E

Page 25: Metabolomics for Characterizing the Human Exposomenas-sites.org/emergingscience/files/2015/06/...VD BPer t t T2D. . . individuals GWAS, RVAS, pathway analysis..etc. EWAS, PheWAS..etc.

NIEHS Exposome workshop (January, 2015): Towards a high-throughput definition of

comprehensive environmental exposures

David Balshaw

Internal exposome

Page 26: Metabolomics for Characterizing the Human Exposomenas-sites.org/emergingscience/files/2015/06/...VD BPer t t T2D. . . individuals GWAS, RVAS, pathway analysis..etc. EWAS, PheWAS..etc.

NIEHS Exposome workshop (January, 2015): Towards a high-throughput definition of

comprehensive environmental exposures

David Balshaw

Internal exposome

External exposome

Page 27: Metabolomics for Characterizing the Human Exposomenas-sites.org/emergingscience/files/2015/06/...VD BPer t t T2D. . . individuals GWAS, RVAS, pathway analysis..etc. EWAS, PheWAS..etc.

NIEHS Exposome workshop (January, 2015): Towards a high-throughput definition of

comprehensive environmental exposures

David Balshaw

Internal exposome

External exposome

Exposome and biological responses (phenomes)

Page 28: Metabolomics for Characterizing the Human Exposomenas-sites.org/emergingscience/files/2015/06/...VD BPer t t T2D. . . individuals GWAS, RVAS, pathway analysis..etc. EWAS, PheWAS..etc.

NIEHS Exposome workshop (January, 2015): Towards a high-throughput definition of

comprehensive environmental exposures

David Balshaw

Internal exposome

External exposome

Exposome and biological responses (phenomes)

Exposome and epidemiology

Page 29: Metabolomics for Characterizing the Human Exposomenas-sites.org/emergingscience/files/2015/06/...VD BPer t t T2D. . . individuals GWAS, RVAS, pathway analysis..etc. EWAS, PheWAS..etc.

NIEHS Exposome workshop (January, 2015): Towards a high-throughput definition of

comprehensive environmental exposures

David Balshaw

Internal exposome

External exposome

Exposome and biological responses (phenomes)

Exposome and epidemiology

Exposome data analytics and informatics

Page 30: Metabolomics for Characterizing the Human Exposomenas-sites.org/emergingscience/files/2015/06/...VD BPer t t T2D. . . individuals GWAS, RVAS, pathway analysis..etc. EWAS, PheWAS..etc.

E:

Can metabolomics provide the analogous, unified, and cost-effective modality for ascertainment of the exposome?

???

image from illumina, inc

Page 31: Metabolomics for Characterizing the Human Exposomenas-sites.org/emergingscience/files/2015/06/...VD BPer t t T2D. . . individuals GWAS, RVAS, pathway analysis..etc. EWAS, PheWAS..etc.

Many challenges in using metabolomics technologies to ascertain exposome…

P = G + E

Page 32: Metabolomics for Characterizing the Human Exposomenas-sites.org/emergingscience/files/2015/06/...VD BPer t t T2D. . . individuals GWAS, RVAS, pathway analysis..etc. EWAS, PheWAS..etc.

Many challenges in using metabolomics technologies to ascertain exposome…

P = G + EMetabolome is both P and E (and G)

Page 33: Metabolomics for Characterizing the Human Exposomenas-sites.org/emergingscience/files/2015/06/...VD BPer t t T2D. . . individuals GWAS, RVAS, pathway analysis..etc. EWAS, PheWAS..etc.

Many challenges in using metabolomics technologies to ascertain exposome…

P = G + EMetabolome is both P and E (and G)

endogenous vs. exogenous untargeted and targeted technologies

temporality and study design

e.g., Athersuch, 2012

Page 34: Metabolomics for Characterizing the Human Exposomenas-sites.org/emergingscience/files/2015/06/...VD BPer t t T2D. . . individuals GWAS, RVAS, pathway analysis..etc. EWAS, PheWAS..etc.

…but possibilities for impactful discovery: big data exposome research examples

time

exposome phenome

pollutants

diet

metabolites . . .

gut flora

height

weightCVD

BPT2D

cancer

xenobiotics . . .

indi

vidu

als

GWAS, RVAS, pathway analysis..etc.

EWAS, PheWAS..etc.

geno

me

(sta

tic)

Data mining of the internal and external exposome

mixtures of exposures

time

drugs

integrative

Figure 1: The exposome is a unified, multi-modal, temporally dependent, and comprehensive digital representation of external and internal environmental exposures linked to humans. Data mining with the exposome can be used to system-atically discover relationships between mixtures of exposures, the genome, and mixtures of traits and diseases. In the example above, diet and gut flora are linked with genomic markers to type 2 diabetes and blood pressure.

mixtures of phenotypes

2015 NIEHS Exposome Workshop (January 2015) Manrai et al (in prep)

Page 35: Metabolomics for Characterizing the Human Exposomenas-sites.org/emergingscience/files/2015/06/...VD BPer t t T2D. . . individuals GWAS, RVAS, pathway analysis..etc. EWAS, PheWAS..etc.

Thank you

[email protected] @chiragjp

www.chiragjpgroup.org


Recommended